New choices for treatment with subcutaneous immunoglobulins
Med Clin (Barc). 2017 Jan 20;148(2):86-90.
doi: 10.1016/j.medcli.2016.09.037.
Epub 2016 Dec 2.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Inmunología, Hospital Universitario 12 de Octubre, Madrid, España. Electronic address: dpleguezuelo@salud.madrid.org.
- 2 Servicio de Inmunología Clínica, Hospital Clínico San Carlos, Madrid, España.
No abstract available
MeSH terms
-
Humans
-
Immunoglobulin G / administration & dosage*
-
Immunoglobulin G / therapeutic use
-
Immunoglobulins / administration & dosage*
-
Immunoglobulins / therapeutic use
-
Immunoglobulins, Intravenous / administration & dosage
-
Immunoglobulins, Intravenous / therapeutic use
-
Immunologic Deficiency Syndromes / drug therapy*
-
Immunologic Factors / administration & dosage*
-
Immunologic Factors / therapeutic use
-
Injections, Subcutaneous
-
Treatment Outcome
Substances
-
Hizentra
-
Immunoglobulin G
-
Immunoglobulins
-
Immunoglobulins, Intravenous
-
Immunologic Factors
-
Vivaglobin